These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2146852)

  • 1. Extrarenal receptor-effector-mechanisms for aldosterone: the sequence of effects on the cellular electrolyte transport in human lymphocytes and their implications for disorders of the water and electrolyte balances.
    Wehling M; Theisen K
    Acta Endocrinol (Copenh); 1990 Oct; 123(4):385-94. PubMed ID: 2146852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Receptor-effector relations in the effect of adosterone on mononuclear leukocytes: validation and application to various water and electrolyte imbalances in humans].
    Wehling M
    Klin Wochenschr; 1989 Jan; 67(1):1-5. PubMed ID: 2537910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension.
    Wehling M; Kuhls S; Kuhnle U; Theisen K
    Klin Wochenschr; 1990 Jan; 68(2):71-6. PubMed ID: 2157089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aldosterone on sodium and potassium concentrations in human mononuclear leukocytes.
    Wehling M; Armanini D; Strasser T; Weber PC
    Am J Physiol; 1987 Apr; 252(4 Pt 1):E505-8. PubMed ID: 2952017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid effector mechanism in human mononuclear leukocytes.
    Armanini D; Wehling M; Weber PC
    J Steroid Biochem; 1987; 27(4-6):967-70. PubMed ID: 2826915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The early mineralocorticoid effector mechanism, the sodium-proton exchanger, is sensitized in lymphocytes from patients with Cushing's syndrome.
    Wehling M; Käsmayr J; Christ M; Sippell W; Theisen K; Müller OA
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):260-5. PubMed ID: 1330384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone-specific membrane receptors and rapid non-genomic actions of mineralocorticoids.
    Wehling M; Eisen C; Christ M
    Mol Cell Endocrinol; 1992 Dec; 90(1):C5-9. PubMed ID: 1338726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel aldosterone receptors: specificity-conferring mechanism at the level of the cell membrane.
    Wehling M
    Steroids; 1994 Feb; 59(2):160-3. PubMed ID: 8191547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast effects of aldosterone on electrolytes in human lymphocytes are mediated by the sodium-proton-exchanger of the cell membrane.
    Wehling M; Käsmayr J; Theisen K
    Biochem Biophys Res Commun; 1989 Nov; 164(3):961-7. PubMed ID: 2556129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity aldosterone binding to plasma membrane rich fractions from mononuclear leukocytes: is there a membrane receptor for mineralocorticoids?
    Wehling M; Christ M; Theisen K
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1306-12. PubMed ID: 1662496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of aldosterone on intracellular sodium and potassium in mononuclear leucocytes from patients with pseudohypoaldosteronism.
    Wehling M; Kuhnle U; Witzgall H; Weber PC; Armanini D
    Clin Endocrinol (Oxf); 1988 Jan; 28(1):67-74. PubMed ID: 3168302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explanation of the pseudohypoaldosteronism (PHA)-stress syndrome with an artificial aldosterone receptor model.
    Herkner K; Pollak A; Swoboda W; Höller B
    J Steroid Biochem; 1984 Jan; 20(1):317-20. PubMed ID: 6231421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nongenomic aldosterone effects: the cell membrane as a specific target of mineralocorticoid action.
    Wehling M
    Steroids; 1995 Jan; 60(1):153-6. PubMed ID: 7792803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudohypoaldosteronism and mineralocorticoid receptor abnormalities.
    Armanini D; Wehling M; Da Dalt L; Zennaro M; Scali U; Keller U; Pratesi C; Mantero F; Kuhnle U
    J Steroid Biochem Mol Biol; 1991; 40(1-3):363-5. PubMed ID: 1659876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inheritance of mineralocorticoid effector abnormalities of human mononuclear leucocytes in families with pseudohypoaldosteronism.
    Wehling M; Kuhnle U; Daumer C; Armanini D
    Clin Endocrinol (Oxf); 1989 Nov; 31(5):597-605. PubMed ID: 2627754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone specific membrane receptors, rapid activation of the sodium-hydrogen exchanger, and cardiovascular implications.
    Wehling M
    Cardiovasc Res; 1995 Feb; 29(2):167-71. PubMed ID: 7736490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aldosterone on intralymphocytic sodium and potassium in patients with primary aldosteronism.
    Wehling M; Kuhls S; Witzgall H; Kuhnle U; Armanini D; Theisen K
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):555-60. PubMed ID: 3425166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes.
    Wehling M
    Heart Fail Rev; 2005 Jan; 10(1):39-46. PubMed ID: 15947890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid actions of aldosterone: lymphocytes, vascular smooth muscle and endothelial cells.
    Christ M; Wehling M
    Steroids; 1999; 64(1-2):35-41. PubMed ID: 10323671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume regulation of human lymphocytes by aldosterone in isotonic media.
    Wehling M; Kuhls S; Armanini D
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E170-4. PubMed ID: 2764099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.